U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H9N3O3S
Molecular Weight 215.23
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFACARBAMIDE

SMILES

NC(=O)NS(=O)(=O)C1=CC=C(N)C=C1

InChI

InChIKey=WVAKABMNNSMCDK-UHFFFAOYSA-N
InChI=1S/C7H9N3O3S/c8-5-1-3-6(4-2-5)14(12,13)10-7(9)11/h1-4H,8H2,(H3,9,10,11)

HIDE SMILES / InChI

Molecular Formula C7H9N3O3S
Molecular Weight 215.23
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Sulfacarbamide is an antimicrobial agent that has been investigated as a therapeutic biochemical for diabetes treatment. Sulfacaramide - has a bacteriostatic effect due to competitive antagonism with PABA, preventing its inclusion in Dihydrofolic acid, which leads to a violation of the synthesis of tetrahydrofolic acid. Thus, the synthesis of nucleic acids is broken, as a result of which the growth and multiplication of microorganisms are suppressed.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Sulfasalazine-EH
Curative
Sulfasalazine-EH
Curative
Sulfasalazine-EH
Curative
Sulfasalazine-EH

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
For adults, a single dose is 0.5-1 g 3-5 r / day. The maximum single dose is 2 g, the maximum daily intake is 7 g. The course of treatment is 6-14 days. For children, the daily dose is 1-2.5 g (in 4-5 receptions).
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
W6CD25Z4QR
Record Status Validated (UNII)
Record Version